The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.
McGurk KA, Zhang X, Theotokis P, Thomson K, Harper A, Buchan RJ, Mazaika E, Ormondroyd E, Wright WT, Macaya D, Pua CJ, Funke B, MacArthur DG, Prasad SK, Cook SA, Allouba M, Aguib Y, Yacoub MH, O'Regan DP, Barton PJR, Watkins H, Bottolo L, Ware JS.
Am J Hum Genet. 2023 Sep 7;110(9):1482-1495. doi: 10.1016/j.ajhg.2023.08.003. Epub 2023 Aug 30.
Revisiting Secondary Dilative Cardiomyopathy.
Kundnani NR, Di Luca F, Meche V, Sharma A, Popa MD, Nicula-Neagu M, Voinescu OR, Iacob M, Duda-Seiman DM, Dragan SR.
Int J Mol Sci. 2025 Apr 28;26(9):4181. doi: 10.3390/ijms26094181.
Cardiomyopathy: An Overview.
Brieler J, Breeden MA, Tucker J.
Am Fam Physician. 2017 Nov 15;96(10):640-646.
Secondary Cardiomyopathy in Polycystic Kidney Disease Syndrome.
Morita H.
Int Heart J. 2019;60(1):10-11. doi: 10.1536/ihj.18-514.
Peripartum cardiomyopathy: A review.
Bala R, Mehta S, Roy VC, Kaur G, de Marvao A.
Rev Port Cardiol. 2023 Nov;42(11):917-924. doi: 10.1016/j.repc.2023.01.029. Epub 2023 Jul 4.
Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.
Meyers DE, Basha HI, Koenig MK.
Tex Heart Inst J. 2013;40(4):385-94.
Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population.
Bourfiss M, van Vugt M, Alasiri AI, Ruijsink B, van Setten J, Schmidt AF, Dooijes D, Puyol-Antón E, Velthuis BK, van Tintelen JP, Te Riele ASJM, Baas AF, Asselbergs FW.
Circ Genom Precis Med. 2022 Dec;15(6):e003704. doi: 10.1161/CIRCGEN.122.003704. Epub 2022 Oct 20.
Phenomapping to Guide Treatment of Ischemic Cardiomyopathy With Secondary Mitral Regurgitation: One Size Does Not Fit All.
Wu KC.
Circ Cardiovasc Imaging. 2024 Apr;17(4):e016573. doi: 10.1161/CIRCIMAGING.124.016573. Epub 2024 Apr 16.
Nonischemic cardiomyopathy with reduced ejection fraction secondary to hyperthyroidism.
Martin MM, Collins MR.
JAAPA. 2021 Jun 1;34(6):27-30. doi: 10.1097/01.JAA.0000735812.69357.c5.
Beta-adrenergic blockade in dilated cardiomyopathy, ischemic cardiomyopathy, and other secondary cardiomyopathies.
Waagstein F.
Heart Vessels Suppl. 1991;6:18-28. doi: 10.1007/BF01752532.
